[Interventional revascularization for cardiovascular disease in patients with chronic kidney disease].

Hideki Ishii, Toyoaki Murohara

Research output: Contribution to journalReview articlepeer-review


Chronic kidney disease (CKD) is an independent risk factor for cardiac mortality. Accelerated atherosclerosis is frequently seen in patients with CKD. However, even in drug eluting stent era, higher restenosis rate after percutaneous coronary intervention (PCI) for coronary artery disease remains a clinical limitation in patients with CKD. Similar tendency is also seen when treated with endovascular therapy (EVT) for peripheral artery disease. Thus, management for atherosclerotic disease is very difficult in patients with CKD. Recent reports have shown that improvement of devices and/or intensive medical treatment may contribute better clinical outcomes after PCI or EVT in patients with CKD. In addition, inflammatory markers such as C-reactive protein may predict worse clinical outcomes including restenosis in such population.

Original languageEnglish
Pages (from-to)339-342
Number of pages4
JournalNippon rinsho. Japanese journal of clinical medicine
Issue number2
Publication statusPublished - 02-2011

All Science Journal Classification (ASJC) codes

  • General Medicine


Dive into the research topics of '[Interventional revascularization for cardiovascular disease in patients with chronic kidney disease].'. Together they form a unique fingerprint.

Cite this